AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA—leaving them both at greater risk ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

A NEW blood test to pick up early signs of a cancer which kills more than half of people within three months of diagnosis is being trialled by UK doctors. The genomic test uses blood samples to ...